Park, Sera
Kim, Geuntae
Choi, Ahyoung
Kim, Sun
Yum, Jung Sun
Chun, Eunyoung
Shin, Hyunjin
Funding for this research was provided by:
Ministry of Trade, Industry and Energy (20014948, 20014948, 20014948)
Article History
Received: 23 April 2024
Accepted: 8 July 2024
First Online: 26 July 2024
Competing interests
: The authors declare no conflict of interest. G.K., E.C. are CHA Vaccine Institute employees. J.S.Y. is the chief executive officer of the CHA Vaccine Institute. CHA Vaccine Institute holds a worldwide license to a patent of L-pampo used in this study. CHA Vaccine Institute partially funded the study.